Multi-target TMS for Schizophrenia Negative Symptoms
NCT:NCT07559084 · NOT_YET_RECRUITING
广告
NCT编号NCT07559084
状态NOT_YET_RECRUITING
开始日期2026-10-01
完成时间2028-01-30
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated
简要摘要
This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the right orbitofrontal cortex (R-OFC), left dorsolateral prefrontal cortex (L-DLPFC), and left inferior parietal lobule (L-IPL) for negative symptoms of schizophrenia.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。